Related Experiment Video
Updated: Oct 13, 2026

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Pseudoexon Activation as a Novel Molecular Mechanism for Chediak-Higashi Syndrome
Irem Eldem1, David B Wilson1, Alexa Dickson2
1Division of Pediatric Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract:
Chediak-Higashi syndrome (CHS) is a hereditary predisposition to hemophagocytic lymphohistiocytosis. We report an adolescent who presented with bicytopenia and progressed to an accelerated phase due to CHS. Neutrophils demonstrated impaired NETosis. Pseudoexon activation in the LYST gene was identified as the underlying molecular mechanism.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Inflammatory Bowel Disease III: Crohn's Disease
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
Anaphase Promoting Complex
